Skip Navigation

This Article
Right arrow Full Text (PDF )
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Psychoyos, A.
Right arrow Articles by Gravanis, A.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Psychoyos, A.
Right arrow Articles by Gravanis, A.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Human Reproduction, Vol. 10, No. suppl_2, pp. 140-150, 1995
© 1995 European Society of Human Reproduction and Embryology

Hormonal anti-implantation agents: antiprogestins

A. Psychoyos1, G. Nikas, L. Sarantis and A. Gravanis2

Hôpital Bicêtre, Bâtiment Gregory Pincus (INSERM) 80 rue du Général Leclerc, Kremlin-Bicâtre 94276, France 2 Department of Pharmacology, School of Medicine, University of Crete Heraklion 71110, Greece

Correspondence: 1To whom correspondence should be addressed

Oestrogens and progestogens separately or in combination are able to prevent implantation with high efficiency, thus acting as interceptive agents. Current interceptive medical regimens include high-dose oestrogens, the association of oestrogens with progestogens or progestogens alone. Compounds with antiprogesterone properties, such as RU 486 (mifepristone) or ZK 98734 (lilopristone), also exhibit a strong interceptive action which, as shown in animal models, is proportional to the dose and the day(s) of administration. Recent clinical studies show that RU 486 can be used successfully for postcoital interception. The regimen applied for this purpose consists of the intake of single dose of 600 mg RU 486 within 72 h of a single act of unprotected intercourse. This treatment was found to be highly effective and to have a more favourably side-effect profile in comparison with the oestrogenprogestogen interceptive regimen. However, because of the induced irregularities of the cycle, the mifepristone regimen, as with the other hormonal methods, should not be used on a regular basis. Currently, all interceptive hormonal regimens are emergency methods. Their occasional use to prevent unwanted pregnancies may reduce the number of therapeutic abortions. However, the frequency and extent of their side-effects do not allow for repeated postcoital use after every act of unprotected intercourse. Obviously, the development of an effective and safe ‘morning after pill’ requires further basic and clinical investigations.

Key words: antiprogestins/implantation/interception/mifepristone RU 486/oestriol


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.